Zhongming Qiu
Clinical trials sponsored by Zhongming Qiu, explained in plain language.
-
New drug trial offers hope for Tough-to-Treat muscle diseases
Disease control Not yet recruitingThis study is testing whether a drug called Telitacicept can help control inflammatory myopathy, a group of diseases where the immune system attacks muscles. Researchers will enroll 30 adults whose symptoms haven't improved enough with standard treatments like steroids or other i…
Phase: PHASE2, PHASE3 • Sponsor: Zhongming Qiu • Aim: Disease control
Last updated Apr 02, 2026 05:26 UTC
-
New drug trial offers hope for debilitating muscle disease
Disease control Not yet recruitingThis early-stage clinical trial is testing whether an experimental drug called ripertamab is safe and effective for treating generalized myasthenia gravis, a chronic autoimmune disease that causes muscle weakness. The study will involve 20 adults who will receive either ripertama…
Phase: PHASE1, PHASE2 • Sponsor: Zhongming Qiu • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC